Primary Site >> Liver Cancer
Gene >> ADAM17
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Liver transplantation for malignant diseases: selection and pattern of recurrence. PMID: 11865357 Ref: Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. PMID: 14607620 |
Ref: Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma. PMID: 17393258 Ref: Genome wide expression profiling identifies genes associated with colorectal liver metastasis. PMID: 17487416 Ref: Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. PMID: 17523307 Ref: [An icteric type hepatocellular carcinoma with no detectable tumor in the liver but with an intrabile duct recurrent tumor]. PMID: 18219911 |
Ref: Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletion. PMID: 18371937 Ref: Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines. PMID: 18452483 |
Ref: MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. PMID: 19296470 Ref: Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma. PMID: 19546556 Ref: [Analysis of differential gene expression in rat hepatic stellate cells activated by culture or hepatocellular carcinoma cell induction]. PMID: 19615251 |
Ref: Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum. PMID: 19727817 Ref: [Risk factors and prognosis for patients with residual tumor after radiofrequency ablation of hepatocellular carcinoma]. PMID: 20510087 Ref: Effects of pro-inflammatory cytokines on the production of soluble fractalkine and ADAM17 by HepG2 cells. PMID: 20922190 |
Ref: Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics. PMID: 22525471 Ref: Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism. PMID: 23108309 Ref: [A case of hepatocellular carcinoma with biliary tumor thrombi treated by extended hepatectomy]. PMID: 23267901 |
Ref: Early recurrence after curative resection in oligonodular hepatocellular carcinoma. PMID: 22945337 Ref: [The analysis of the efficacy and safety of combined transarterial chemoembolization with sorafenib in patients with large hepatocellular carcinoma]. PMID: 23886261 Ref: Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity. PMID: 24172289 |
Ref: miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17. PMID: 23621665 Ref: Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. PMID: 24308993 Ref: Antitumor function of microRNA-122 against hepatocellular carcinoma. PMID: 24531873 Ref: Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus. PMID: 24718422 Ref: Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma. PMID: 24969373 Ref: Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. PMID: 25028783 Ref: Caveolin-1 is required for TGF-beta-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17. PMID: 25032849 Ref: MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma. PMID: 25174729 Ref: [Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer]. PMID: 25731453 |
Ref: Effective activity of cytokine induced killer cells against hepatocellular carcinoma including tumor-initiating cells. PMID: 25636604 Ref: Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis. PMID: 25744849 Ref: Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique. PMID: 25816994 Ref: [Pre-Operative Treatment with Transcatheter Arterial Chemoembolization (TACE) and Hepatic Arterial Infusion (HAI) for Liver Metastasis from Gastric Cancer--A Case Report]. PMID: 26805063 |
Ref: Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. PMID: 26711803 Ref: Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation. PMID: 26993601 Ref: Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma. PMID: 27094483 Ref: Association between the expression of HIF-1alpha and VEGF and prognostic implications in primary liver cancer. PMID: 27173353 |
Ref: Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus. PMID: 28076848 Ref: The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma. PMID: 28178663 Ref: Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study. PMID: 28205111 Ref: Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. PMID: 28751722 Ref: Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signaling. PMID: 28903370 Ref: The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in Chinese hepatocellular carcinoma patients. PMID: 29050244 Ref: Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and disease-free survival. PMID: 29212179 |
Ref: Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL? PMID: 29086058 Ref: Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells. PMID: 29873070 Ref: ADAM17 promotes cell migration and invasion through the integrin beta1 pathway in hepatocellular carcinoma. PMID: 29966664 Ref: Recent developments with immunotherapy for hepatocellular carcinoma. PMID: 29995439 Ref: iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway. PMID: 30297396 |